<DOC>
	<DOCNO>NCT00730249</DOCNO>
	<brief_summary>Investigation efficacy high-dose extended-release Methylphenidate adult ADHD , compare placebo</brief_summary>
	<brief_title>Quality Assurance Administering Methylphenidate Adults With Attention Deficit Hyperactivity Disorder ( ADHD ) - QUMEA</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<criteria>patient treat outpatient score 85 great IQtest ( MWTB ) diagnosis ADHD accord ADHSCL ( DSM IV ) WRAADDS &gt; 35 point ADHD symptom exist since childhood ( WURSk &gt; = 30 ) Body Mass Index &gt; = 20 body weight &lt; 130 kg willing eat breakfast lunch patient willing able come observation appointment write consent patient participate study treatment psychostimulants past two week screen shift work night work alcohol , medication drug dependency past six month manifest drug abuse diagnosis psychosis ( SKIDI ) epileptic attack past EEG result suggest epilepsy acute depressive episode accord ICD10 F32.2 ICD10 F32.3 ( BeckDepressionInventory &gt; 18 ) Illness schizophrenic symptom ( SKIDI ) acute manic episode , bipolar disorder ( SKIDI ) diagnosis tic disorder acute anorexia acute prominent panic disorder generalise anxiety ( SKIDI ) clinically relevant kidney disorder creatinine &gt; 1,5 x upper normrange clinically relevant liver disorder SGOT and/or SGPT &gt; 2 x upper normrange pathological ECGfinding QTc &gt; 450 msec male , QTc &gt; 470 msec female high blood pressure ( anamnesis blood pressure &gt; 140/90 mm Hg screening ) know acclusive arterial disease angina pectoris ( anamnesis ECGfinding ) cardiac arrhythmia ( anamnesis ECGfinding ) KHK ( anamnesis ECGfinding ) post heartattack status ( anamnesis ECGfinding ) post stroke status know elevate intraocular pressure know enlarged prostate latent manifest hyperthyreosis TSH &lt; low normrange patient terminal disease ( e.g . cancer ) participation clinical study within past 30 day participation study earlier point time simultaneous participation another clinical trial woman childbearing age without adequate contraception ( contraceptive , intrauterine device , sexual intercourse ) pregnancy ( positive pregnancy test ) lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>adult</keyword>
	<keyword>methylphenidate hydrochloride</keyword>
	<keyword>Medikinet retard</keyword>
	<keyword>control clinical trial</keyword>
	<keyword>safety</keyword>
	<keyword>randomize , double-blind , placebo-controlled trial</keyword>
	<keyword>treatment</keyword>
	<keyword>central nervous system stimulant</keyword>
	<keyword>therapeutic us</keyword>
</DOC>